Company Filing History:
Years Active: 2008-2010
Title: Lixin Jiang: Innovator in Gene Delivery Systems
Introduction
Lixin Jiang is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of gene delivery systems, particularly in the development of adeno-associated viral (AAV) vectors. With a total of 2 patents, Jiang's work is paving the way for advancements in gene therapy.
Latest Patents
One of Jiang's latest patents focuses on tetracycline-regulated adeno-associated viral (AAV) vectors for gene delivery to the nervous system. This innovative vector includes a first nucleic acid, a second nucleic acid, inverted terminal repeats of adeno-associated virus, and a tetracycline-off regulatable promoter system. The system features a first promoter operably linked to the first nucleic acid and a second promoter operably linked to the second nucleic acid. The promoters drive expression in opposite directions and away from the inverted terminal repeats. The method involves providing a recombinant adeno-associated viral (rAAV) vector and administering it to a nervous system cell. The expression of a product from the first nucleic acid is regulatable by the promoter system.
Career Highlights
Lixin Jiang is currently associated with Children's Memorial Hospital, where he continues to advance his research in gene delivery systems. His work is crucial in the ongoing efforts to improve therapeutic options for neurological conditions.
Collaborations
Jiang has collaborated with notable colleagues, including Martha C Bohn and Neva C West. These partnerships enhance the research environment and contribute to the success of their projects.
Conclusion
Lixin Jiang's innovative work in gene delivery systems exemplifies the potential of modern biotechnology. His contributions are vital for the future of gene therapy and its applications in medicine.